Abbott Laboratories
Jul 21, 2008
UK's NICE rejects second go with arthritis drugs
Three rheumatoid arthritis drugs should not be given to patients on Britain's state-run health service when similar drugs have already failed, the country's healthcare cost-effectiveness body said on Monday.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Sugar in popular Similac Organic baby formula r... | Sep 26 | dac | 8 |
| American Diabetes Association Announces New Lat... | Sep 17 | Pumper | 1 |
| Abbott plans global cost-cutting | Aug '08 | Uh Oh | 14 |
| FDA backs Abbott stent | Aug '08 | Stent Lady | 1 |
| Had a knack for generating ideas | Aug '08 | Allison Youn... | 1 |
| Abbott profit beats Wall Street estimates for 2Q | Jul '08 | Uhh | 9 |
| FDA panel opposes Depakote warning | Jul '08 | Deeptoad | 1 |
Aries
Most Popular